SynthesisEuropean journal of clinical pharmacology2024

Time-course and dose-effect of omalizumab in treating chronic idiopathic urticaria/chronic spontaneous urticaria.

Aiping Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.